Differentiation of imatinib -resistant chronic myeloid leukemia cells with BCR-ABL-T315I mutation induced by Jiyuan Oridonin A
Yun Xu(Weifang Medical University), Zhe‐Sheng Chen(St. John's University)
Cited by 5
Related Papers
Microbiota in health and diseases
|Signal Transduction and Targeted Therapy|2022|2.9k
Lapatinib (Tykerb, GW572016) Reverses Multidrug Resistance in Cancer Cells by Inhibiting the Activity of ATP-Binding Cassette Subfamily B Member 1 and G Member 2
|Cancer Research|2008|385
Recent advances in biomimetic nanodelivery systems: New brain-targeting strategies
|Journal of Controlled Release|2023|100